This provides nearly a year of advance for ASM participants to prepare for IA-2
This extensive distribution, combined with rapid plasma clearance, suggests tissue binding or cellular uptake contributes to the peptide's pharmacological effects
BPC-157 travels freely through harsh environments without losing its biological potency
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
adequate water intake to support CSF and endolymph dynamics
WHERE IT TREATS Muscles, tendons, ligaments, joints, and the gastrointestinal tract